| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 100.061 | 75 |
| GSM780708 | Untreated after 4 days (C2_1) | 92.1717 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 78.2053 | 71 |
| GSM780719 | Untreated after 4 days (C1_2) | 93.4204 | 74 |
| GSM780720 | Untreated after 4 days (C2_2) | 82.49 | 72 |
| GSM780721 | Untreated after 4 days (C3_2) | 93.2393 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 92.3298 | 74 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 117.923 | 77 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 95.2064 | 75 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 74.454 | 70 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 111.087 | 77 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 86.3931 | 73 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 125.013 | 78 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 88.6565 | 73 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 100.846 | 75 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 138.262 | 79 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 109.91 | 77 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 103.898 | 76 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 88.8209 | 73 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 91.1671 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 99.1121 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 102.514 | 76 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 97.305 | 75 |